×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
RISK COMMUNICATION AND TRANSPARENCY
Session Chair(s)
Jan Petracek, MD, MSc
CEO
Ivigee, Czech Republic
Determinants of impact of Drug Safety Warnings. A retrospective analysis of Direct Healthcare Professional Communications.
Learning Objective : understand when Direct Healthcare Professional Communication affect drug prescribing need for further evaluation of effectiveness of regulatory risk communication
Speaker(s)
Role of PRAC in Transparency and Communication
Mick Foy
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Director of Delivery
Impact of Increased Transparency on the Industry
Angelika Joos, MPharm
MSD, Belgium
Executive Director, Global Regulatory Policy
Determinants of impact of Drug Safety Warnings. A retrospective analysis of Direct Healthcare Professional Communications.
Peter Mol, PharmD, PhD
MEB, Netherlands
CHMP member, NL
Have an account?